Concepedia

Thomas Knickelbine

TK

Statistics

Publications

33

Citations

2.1K

H-Index

22

Active since

1997

Affiliations

Minneapolis Heart Institute Foundation(Current)

Abbott Northwestern Hospital

University of Minnesota

Allina Health

Brigham and Women's Hospital

Thomas Knickelbine is an author at Minneapolis Heart Institute Foundation specializing in medicine, cardiology, and cardiovascular disease.

ORCID

Publications per year

1997–2022

33

Publications

33

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

, , +15

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US

Christopher P. Cannon, James A. de Lemos, Robert S. Rosenson et al. · JAMA Cardiology · 2021 · 225 citations · Full text

, , +17

Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults

Michael D. Miedema, Zeina Dardari, Khurram Nasir et al. · JAMA Network Open · 2019 · 145 citations · Full text

, , +13

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

, , +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

, , +17

1–5 of 33